Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

NCT03798301 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

CMV Infection
Cytomegalovirus Infections
CMV Viremia
Opportunistic Infections

Interventions

BIOLOGICAL: CMV-specific T-cells

Sponsor

University of Wisconsin, Madison